GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
New
Increased
Maintained
Reduced
Closed
Funds Holding
3,387
Funds Holding Change
-70
Funds Holding Growth
-2%
Value
$550B
Holding in Top 10
548
Top 10 Change
+121
Top 10 Growth
+28%
Value Growth
-9%
New
163
Increased
1,411
Reduced
1,619
Closed
174
Capital Inflow
$23.9B
Capital Outflow
$25.7B
Net Capital Flow
-$1.81B
Capital Flow Change
-$3.26B
Calls
$5.08B
Puts
$5.51B
Net Calls
-$430M
Put/Call Ratio
1.08